<i>Salvia miltiorrhiza</i> and Its Compounds as Complementary Therapy for Dyslipidemia: A Meta-Analysis of Clinical Efficacy and In Silico Mechanistic Insights

<i>Salvia miltiorrhiza</i> and Its Compounds as Complementary Therapy for Dyslipidemia: A Meta-Analysis of Clinical Efficacy and In Silico Mechanistic Insights

<b>Background/Objectives:</b> Dyslipidemia is a significant risk factor for atherosclerotic cardiovascular disease (ASCVD), a leading cause of death worldwide. <i>Salvia miltiorrhiza</i> Burge is widely used in East Asia for cardiovascular health, showing potential benefits i...

Full description

Saved in:
Bibliographic Details
Main Authors: Min-Seong Lee, Han-Young Lee, Seung-Hyun Oh, Chang-Bum Kim, Ji-Han Kim, Seung-Hoon Yoo, Yeon-Joo Yoo, Su-Yeon Lee, Byung-Cheol Lee
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Pharmaceuticals
Subjects:
dyslipidemia
<i>Salvia miltiorrhiza</i>
meta-analysis
network pharmacology
Online Access:https://www.mdpi.com/1424-8247/17/11/1426
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<b>Background/Objectives:</b> Dyslipidemia is a significant risk factor for atherosclerotic cardiovascular disease (ASCVD), a leading cause of death worldwide. <i>Salvia miltiorrhiza</i> Burge is widely used in East Asia for cardiovascular health, showing potential benefits in lowering cholesterol and reducing inflammation. <b>Methods:</b> This study systematically reviewed and conducted a meta-analysis of randomized controlled trials (RCTs) to assess the clinical effectiveness of <i>Salvia miltiorrhiza</i> in treating dyslipidemia. Moreover, network pharmacology and molecular docking analyses were performed to explore the mechanisms underlying the effects of <i>Salvia miltiorrhiza</i>. <b>Results:</b> The meta-analysis revealed that when <i>Salvia miltiorrhiza</i> is combined with statin therapy, it significantly enhances lipid profiles, including reductions in total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides and improvements in high-density lipoprotein cholesterol (HDL-C), compared to statin therapy alone. The in silico analyses indicated that <i>Salvia miltiorrhiza</i> may influence key biological pathways, such as the PI3K/Akt, JAK/STAT, and HMGCR pathways, which are involved in inflammation, lipid metabolism, and the development of atherosclerosis. <b>Conclusions:</b> <i>Salvia miltiorrhiza</i> shows potential as a complementary therapy for dyslipidemia, offering additional lipid-lowering and anti-inflammatory benefits.
ISSN:1424-8247

Similar Items